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Abstract: In part I of this review, the authors showed how poly(amidoamine) (PAMAM)-based
dendrimers can be considered as promising delivering platforms for siRNA therapeutics. This is
by virtue of their precise and unique multivalent molecular architecture, characterized by uniform
branching units and a plethora of surface groups amenable to effective siRNA binding and delivery
to e.g., cancer cells. However, the successful clinical translation of dendrimer-based nanovectors
requires considerable amounts of good manufacturing practice (GMP) compounds in order to conform
to the guidelines recommended by the relevant authorizing agencies. Large-scale GMP-standard
high-generation dendrimer production is technically very challenging. Therefore, in this second part
of the review, the authors present the development of PAMAM-based amphiphilic dendrons, that are
able to auto-organize themselves into nanosized micelles which ultimately outperform their covalent
dendrimer counterparts in in vitro and in vivo gene silencing.
Keywords: RNAi therapeutics; siRNA delivery; amphiphilic dendrons; PAMAM dendrimers;
self-assembling; nanovectors; gene silencing
1. Self-Assembling PAMAM-Based Amphiphilic Dendrons: A New Paradigm for siRNA Delivery
In its broadest sense, self-assembly describes the natural tendency of physical systems to
exchange energy with their surroundings and assume patterns or structures of low free energy.
Random thermal motions bring constituent particles together in various configurations, and only
those with significantly favorable interaction energy forming, tend to persist, and eventually become
predominant. The information on the shape and size of the ultimate self-assembled entity is embodied
in the structures of the individual components. A system slowly approaching equilibrium assumes
a simple repetitive structure, while a dynamic system may generate structures of great complexity.
For example, molecules in a cooling glass of water self-assemble as simple ice crystals, while the same
molecules in a turbulent cloud with temperature and humidity gradients self-assemble as complex
snowflakes of enormous variety. In relation to chemistry, self-assembly constitutes the quintessence
of nanotechnology-based techniques leading to the design of novel materials [1–4]. It relies on the
cumulative effects of multiple non-covalent interactions to assemble molecular building blocks into
supramolecular entities in a reversible, controllable, and specific way, yet with relatively little synthetic
effort. In particular is the ability of self-assembled structures to behave as more than the sum of their
individual parts, and exhibit completely new properties [5].
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With these concepts in mind, the authors envisaged the idea of creating small amphiphilic
poly(amidoamine) (PAMAM)-based dendrons which, upon auto-organization into nanosized micelles,
could mimic the covalent, high-generation dendrimer counterparts in size, shape and function,
in particular for in vitro and in vivo siRNA delivery [6–8], as set out below.
2. siRNA Delivery by Single-Tail Self-Assembling Amphiphilic Dendrons
2.1. Design, Optimization and Chemico-Physical Characterization of Single-Tail Self-Assembling
Amphiphilic Dendrons
Our work in this field started with the design, optimization and synthesis of a series of amphiphilic
dendrons (1–6) characterized by a single hydrophobic alkyl chain of variable length and a hydrophilic
PAMAM head with 8 primary amine terminal groups [7], as shown in Scheme 1. In addition,
two non-amphiphilic dendrons characterized by a hydrophilic pentaethylene glycol (PEG) chain (7)
and by the presence of the sole PAMAM head (8) were also produced as negative reference compounds.
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Scheme 1. The chemical structure of the PAMAM-based self-assembling amphiphilic dendrons bearing
a single alkyl chain of variable length (1–6). The two non-amphiphilic dendrons characterized by
a hydrophilic pentaethylene glycol (PEG) chain (7) and by the presence of the sole PAMAM head (8)
used as negative reference compounds are also shown (see text for details). Adapted from [7] with the
permission of John Wiley and Sons, 2016.
Mesoscale simulati ns (see Figure S1, T ble S1, and text in Supporting I formation for details)
were initially employed to predict the self-assembly of all dendrons 1–8. According to the in silico
results, the amphiphilic dendrons 1–6 were able to auto-organize into spherical nanosized micelles
(shown in Figure 1 for dendrons 4, 3 and 2 as an example), with an average diameter D and aggregation
number Nagg ranging from 5.6 nm and 5 for micelles. This was generated by dendron 1 to 8.1 nm
and 13 for those originate by the self-assembling of dendron 6 (Table 1). Contextually, no stable
nanostructure formation was observed for the negative controls 7 and 8, as shown in the left panel of
Figure 1d for dendron 8.
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amphiphilic dendrons bearing a longer hydrophobic component are able to self-assemble and pack 
more efficiently than those characterized by shorter alkyl tails. In addition, the associated values of 
the free energy of micellization (ΔGm) predicted by simulation (see Supporting Information for 
details) were all largely negative, supporting the spontaneous and thermodynamically favored 
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amphiphilic dendrons, the differential contribution to ΔGm (and hence to CMC) is obviously related 
to the length of the hydrophobic chain. 
Experimental confirmation of in silico predictions were first performed by dynamic light 
scattering (DLS) and transmission electron microscopy (TEM). Both these techniques confirmed that 
the amphiphilic dendrons predominantly formed nanosized spherical micelles, as shown in Figure 2 
Figure 1. The computer simulation of the self-assembled micelles generated by the amphiphilic
dendrons 4 (a), 3 (b), and 2 (c). In all panels, the hydrophilic PAMAM head is portrayed as purple
and lilac beads, the hydrophobic tail is represented by light gray beads while the linker between
the hydrophilic and the hydrophobic portion of the molecule is shown as green beads. Water and
counterions are portrayed as a gray field for clarity. The right images in each panel show only the
micellar cores. (d, left) Zoomed view of the micelles formed by dendron 4. The micellar cores are
highlighted by a light gray surface. (d, right) Computer simulation of the non-amphiphilic dendron 8
selected as negative control, showing the non-self-assembling characteristics of this system.
Table 1. Micelle aggregation number (Nagg), surface charge density (σm, e/nm2), diameter (D, nm),
critical micelle concentration (CMC, µM) and free energy of micellization (∆Gm, kJ/mol) for dendrons
1–6 as predicted by computer si ulations. The corresponding experimental values of the icelle
diameter (Dexp, nm) and critical micelle conce tration (CMCexp, µM) are also reported. Adapted from
[7] with the permission of John Wiley and Sons.
Dendron Nagg D Dexp CMC CMCexp ∆Gm
1 5 5.6 ± 0.1 - 415 398 ± 22 −38.7
2 6 5.9 ± 0.1 - 127 116 ± 11 −44.4
3 7 6.2 ± 0.1 6.6 ± 0.1 37.2 49.9 ± 3.3 −50.5
4 8 6.4 ± 0.1 6.8 ± 0.1 11.4 15.6 ± 1.1 −56.4
5 10 7.1 ± 0.2 7.3 ± 0.1 9.13 11.2 ± 0.6 −57.5
6 13 8.1 ± 0.2 7.8 ± 0.2 8.50 8.24 ± 3.8 −57.8
The values of the critical micelle concentration (CMC) for the amphiphilic dendrons 1–6
(see Supporting Information for details) were further investigated from which a clear inverse
relationship between the hydrophobic tail length and the CMC was obtained (Table 1). In other
words, the amphiphilic dendrons bea ing a longer hydrophobic comp ent are able to self-assemble
and pack more efficiently than those characterized by shorter alkyl tails. In addition, the ass ciated
values of the free energy of micellization (∆Gm) predicted by simulation (see Supporting Inf rmation
for details) were all largely negative, supporting the spontaneous and thermodynamically favored
micelle formation for all dendrons 1–6 (Table 1). As the hydrophilic portion was the same in all
amphiphilic dendrons, the differential contribution to ∆Gm (and hence to CMC) is obviously related to
the length of the hydrophobic chain.
Experimental confirmation of in silico predictions were first performed by dynamic light
scattering (DLS) and transmission electron microscopy (TEM). Both these techniques confirmed that
the amphiphilic dendrons predominantly formed nanosized spherical micelles, as shown in Figure 2
for dendrons 3–6. In particular, data analysis confirmed that an increase of the hydrophobic tail
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length from C14 (3) to C22 (6) was paralleled by an increase of the micellar diameter Dexp from 6.6 nm
to 7.8 nm, in full agreement with the computer-based predictions (Table 1). Quite interestingly,
the overall dimensions of these micellar nano-objects are indeed very close to those characterizing
the high-generation structurally flexible triethanolamine (TEA)-core covalent dendrimers discussed
in detail in the companion paper [9] (e.g., the average molecular diameters for generation 4, 5 and
6 TEA-core dendrimers are equal to 5.2, 7.7 and 10.1 nm, respectively). Therefore, at least from
the standpoint of structure and dimensions, the self-assembled nanoparticles obtained from the
amphiphilic dendrons can be considered as supramolecular dendrimer mimics.
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Figure 2. TE i ages of spherical micelles formed by the amphiphilic dendrons 3–6. Adapted from [7]
with the permission of John Wiley and Sons, 2016.
fi
fl t probe (Table 1). The progressive increase in alkyl chain length resulted in a drop of CMCexp
from 398µM for dendron 1 to 8.24µM for dendron 6. The high values f the computational/experimental
CMC for systems 1 and 2 re the likely reason why micelle formation by these two dendrons was
not ob rved under the conditions adopted for DLS/TEM experiments. Further, in agr ement wi h
the simulation, no CMC value co d be experimentally determined for 7 and 8, confirming the
non-self-asse bling properties of these two negative-control systems.
2.2. In Silico/Experi ental Interaction of Single Tail Self- sse bling endrons and siRNA
esoscale simulations were again exploited for predicting the interactions between the amphiphilic
dendrons 1–8 and siRNA molecules, as illustrated in Figure 3.
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Figure 3. Morphologies of the s ste s formed at a dendrimer-to-siRNA charge ratio (N/P) = 10 by
the siRNA molecules and the amphiphilic dendrons 1 (a), 2 (b), 3 (c), 4 (d), 5 (e), 6 (f), 7 (g) and 8 (h)
as obtained from molecular simulations. Left panels are zoomed images of the right panels. Colors
as in Figure 2, except for the siRNA molecules, shown as red sticks and the water and counterions,
portrayed in the left panels as light blue field for clarity. Adapted from [7] with the permission of John
Wiley and Sons, 2016.
The computer images showed that, at the same dendrimer-to-siRNA charge ratio (N/P) of 10,
the nucleic acid fragments are well encased within the micellar network formed by all self-assembling
amphiphilic d ndrimers 1–6 and so are efficiently protected from the surrou ding nvironme t. For the
non-self-assembling systems 7 and 8, the siRNA molecules are interspersed within an unorganized
solution of sin le dendrons and water, and therefore in principle more susceptible to ultimate
degradation by e.g., RNAses.
The in silico quantitative characterization of the siRNA/amphiphilic dendron interactions was
next carried out by atomistic molecular dynamics (MD) simulations performed in the framework of
the so-called molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) methodology [9–15]
(the methodology is described in detail in the Supporting Information in the companion paper [9]).
The values of free energy of binding (∆Gbind) between the different self-assembling dendrons 1–6 towards
the siRNA sequence directed against the mRNA coding for the heat shock protein 27 ( sp27)—a small
molecula chaper ne wh ch is a vital regulator of cell survival and a major player in drug resistance—were
initially calculated, as listed in the first column of Table 2. However, in order to perform a rigorous
discussion about these aspects, the concept of effective free energy of binding (∆Gbind,eff) was introduced,
as follows. From an extensive analysis of each dendron micelle/siRNA complex MD trajectory, the number
Neff of dendron branches (each bearing a positive charge) in permanent contact with the siRNA was
determined, leading to the values listed in the second columns of Table 2. The precise identification of
each dendrimer branch involved in the siRNA binding, and the corresponding individual contribution
afforded to the overall binding energy, was then carried out by a per-residue free energy decomposition
technique (described in th Supporting Information in the companion paper [9]). The cumulative
results of this analysis ar r ported in the third column of Table 2, showing th effective contribution
to the total free nergy of bindi g (∆Gbind,eff). Howev r, to be able to compare simulation data among
themselves (and with experimental data, see below) the effective-charge-normalized values of ∆Gbind,eff,
i.e., ∆Gbind,eff/Neff, were considered, as shown in the fifth column of Table 2.
Table 2. The free energy of micellization (∆Gbind, kcal/mol), number of effective charges (Neff), effective
free energy of binding (∆Gbind,eff, kcal/mol), and effective-charge-normalized free energy of binding
(∆Gbind,eff/Neff) between siRNA and dendrons 1–6 as derived from molecular simulations. The last
column reports the siRNA/dendron binding data (C50, µM) obtained from ethidium bromide (EB)
displacement assays. Adapted from [7] with the permission of John Wiley and Sons, 2016.
Dendron ∆Gbind Neff ∆Gbind,eff ∆Gbind,eff/Neff C50
1 −8.23 ± 0.91 13 ± 1 −2.47 ± 0.32 −0.19 ± 0.03 -
2 −13.4 ± 1.1 18 ± 1 −4.30 ± 0.45 −0.24 ± 0.03 42.0 ± 2.0
3 −17.1 ± 1.3 22 ± 1 −6.00 ± 0.36 −0.27 ± 0.02 16.9 ± 0.5
4 −22.6 ± 1.2 31 ± 1 −12.7 ± 0.41 −0.41 ± 0.04 7.0 ± 0.3
5 −46.6 ± 1.6 49 ± 1 −28.9 ± 0.70 −0.59 ± 0.04 5.3 ± 0.4
6 −57.8 ± 2.3 62 ± 1 −34.7 ± 0.62 −0.56 ± 0.05 4.8 ± 0.1
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From the values reported in Table 2, the effective interaction between the micelles formed by the
different dendrons with siRNA (∆Gbind,eff) increases with increasing alkyl chain length, the last three
dendrons definitely being the strongest siRNA binders in the order: 4 < 5 < 6. Limiting the discussion
to these three self-assembling systems, the micelles formed by dendron 4 were characterized by a total
number of charges equal to +64, the 48% of which (Neff = 31 are involved in productive siRNA binding.
This translates into the corresponding ∆Gbind,eff/Neff value of −0.41 kcal/mol. In contrast, the other two
efficient self-assembled micelles generated by dendrons 5 and 6 were not only both able to exploit 61%
of their positive charges (49/80 and 62/102 for 5 and 6, respectively) but they also did it more efficiently
(∆Gbind,eff/Neff = −0.59 kcal/mol for 5 and −0.56 kcal/mol for 6, Table 1), ultimately characterizing the
corresponding micelles as the best siRNA binders of the whole series.
In silico data were experimentally confirmed by fluorescent ethidium bromide (EB) displacement
assays (see Figure A1 in Appendix A). According to these tests, the value of C50 (i.e., the dendron
concentration at which the fluorescence of siRNA-intercalated EB is reduced by 50%), is an indication
of siRNA binding efficiency: The lower the C50 value, the stronger the siRNA/micelle binding. As seen
in Figure A1, the negative-control (i.e., non-self-assembling) dendrons 7 and 8 were not able to displace
EB from the nucleic acid. In line, also for the self-assembling dendron 1, bearing the shortest alkyl tail
(C14), the C50 value was not determined, due to the high CMC value required for its self-assembly.
On the other hand, for the dendron series 2–6, progressively decreasing C50 values were obtained
(Figure A1 and Table 2, last column), with dendron 6 being the most effective siRNA binder, in full
agreement with computer-based predictions.
2.3. In Vitro siRNA Delivery Performance of Single-Tail Self-Assembling Dendrons
Based on the results described above, dendrons 4–6 were selected for in vitro delivery of siRNA
molecules targeting both the Hsp27 and the translationally controlled tumor protein (TCTP, a highly
conserved protein present in all eukaryotic organisms that regulate cell survival in human tumors)
in human castration-resistant prostate cancer (HCPC) PC-3 and C4-2 cell lines (Figure 4a,b). In these
experiments, all other dendrons (1, 3, 7 and 8) were also tested for comparison and/or negative controls.
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to these three self-assembling systems, the micelles formed by dendron 4 were characterized by a 
total number of charges equal to +64, the 48% of which (Neff = 31 are involved in productive siRNA 
binding. This translates into the corresponding ΔGbind,eff/Neff value of −0.41 kcal/mol. In contrast, the 
other two efficient self-assembled micelles generated by dendrons 5 and 6 were not only both able to 
exploit 61% of their positive charges (49/80 and 62/102 for 5 and 6, respectively) but they also did it 
more efficiently (ΔGbind,eff/Neff = −0.59 kcal/mol for 5 and −0.56 kcal/mol for 6, Table 1), ultimately 
characterizing the corresponding micelles as the best siRNA binders of the whole series. 
In silico data were experimentally confirmed by fluorescent ethidium bromide (EB) 
displacement assays (see Figure A1 in Appendix A). According to these tests, the value of C50 (i.e., 
the dendron concentration at which the fluorescence of siRNA-intercalated EB is reduced by 50%), is 
an indication of siRNA binding efficiency: The lower the C50 value, the stronger the siRNA/micelle 
binding. As seen in Figure A1, the negative-control (i.e., non-self-assembling) dendrons 7 and 8 were 
not able to displace EB from the nucleic acid. In line, also for the self-assembling dendron 1, bearing 
the shortest alkyl tail (C14), the C50 value was not det rmin d, due to the high CMC value required 
for its self-assembly. On the other hand, for the dendron series 2–6, progressively decreasing C50 
values were obtained (Figure A1 and Table 2, last column), with dendron 6 being the most effective 
siRNA binder, in full agreement with computer-based predictions. 
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Sons, 2016. 
As shown in this Figure, the best siRNA delivery capacity was obtained with the nanovector 
based on the self-assembled form of dendron 4, whose related gene silencing effect was even superior 
to that obtained both with the gold standard commercial vector Lipofectamine and with the high-
generation (G7) covalent PAMAM-based dendrimer. This featured an extended triethanolamine 
(TEA) core developed by our group and discussed in detail in the companion paper [9]. As 
anticipated by in silico predictions, nanocarriers formed by dendrons bearing shorter aliphatic (1–3), 
hydrophilic (7) or no chains (8) fail to elicit meaningful gene silencing in all cases. Indeed, while 7 
and 8 are intrinsically unable to self-assembly (negative controls), the former dendron set (1–3) likely 
cannot generate stable micelles and/or siRNA complexes at the experimental conditions employed 
for transfection, due to their high CMC and C50 values (Tables 1 and 2). On the other hand, 
nanomicelles from dendrons with longer alkyl tails (5 and 6) were also able to achieve significant 
siRNA delivery and silenced the target Hsp27 and TCTP genes, yet with performance lower than that 
obtained with dendron 4. 
These last results seem to be in slight contradiction with the computer-based prediction reported 
in Table 2, according to which the best (i.e., most favorable) values of ΔGbind,eff/Neff and C50 are indeed 
obtained for self-assembled dendrons 5 and 6. This ranks these nanovectors as the tightest siRNA 
binders. To investigate whether this disagreement was real or only apparent, cellular uptake 
experiments based on flow cytometry were performed using siRNA in complex with micelles from 
4, 5, and 6 (Figure 5a). These data clearly show that this step is not governing the differential behavior 
of these nanovector/siRNA performance along the in vitro gene silencing pathway, as all three 
systems are characterized by comparable cellular uptake efficiency. 
- sse bled dendron-mediated siRNA delivery and gene sil ncing of Hsp27 (a) and TCTP
proteins (b) in human prostate canc r PC-3 (solid bars) and C4-2 (patterned bars) cell lin s (N/P = 10).
Control: Untreated c lls. Th results obtained from non-self-assemb ing d ndro s 1, 7 and 8 are also shown
for negative-c ntrol purposes. (c) Exp ession of Hsp27 in PC-3 cell treated with 50 nM siRNA delivered by
elf-assembled dendron 4 (N/P = 10), by Lipofectamine, and by the high-generation covale t triethanolamine
(TEA)-core PAMAM-based dendrim r G7. Control: Untreated c lls. Negative controls: Se f-assembl
dendron 4 alone a d a scrambled (i.e., non-silenci g) siRNA sequen e. The expr ssion levels of Hsp27 and
TCTP proteins were quantifi d by western blots 72 h post treatment using vi culin as the control. Adapted
fr m [7] with the permission of John Wiley and Sons, 2016.
As shown in this Figure, the best siRNA delivery capacity was obtained with the nanovector based
on the self-assembled form of dendron 4, whose related gene silencing effect was even superior to that
obtained both with the gold standard commercial vector Lipofectamine and with the high-generation
(G7) covalent PAMAM-based dendrimer. This featured an extended triethanolamine (TEA) core
developed by our group and discussed in detail in the companion paper [9]. As anticipated by in silico
predictions, nanocarriers formed by dendrons bearing shorter aliphatic (1–3), hydrophilic (7) or no
chains (8) fail to elicit meaningful gene silencing in all cases. Indeed, while 7 and 8 are intrinsically
unable to self-assembly (negative controls), the former dendron set (1–3) likely cannot generate stable
micelles and/or siRNA complexes at the experimental conditions employed for transfection, due to
their high CMC and C50 values (Tables 1 and 2). On the other hand, nanomicelles from dendrons with
longer alkyl tails (5 and 6) were also able to achieve significant siRNA delivery and silenced the target
Hsp27 and TCTP genes, yet with performance lower than that obtained with dendron 4.
These last results seem to be in slight contradiction with the computer-based prediction reported
in Table 2, according to which the best (i.e., most favorable) values of ∆Gbind,eff/Neff and C50 are
indeed obtained for self-assembled dendrons 5 and 6. This ranks these nanovectors as the tightest
siRNA binders. To investigate whether this disagreement was real or only apparent, cellular uptake
experiments based on flow cytometry were performed using siRNA in complex with micelles from 4,
5, and 6 (Figure 5a). These data clearly show that this step is not governing the differential behavior of
these nanovector/siRNA perfor ance along the in vitro gene silencing pathway, as all three systems
are characterized by comparable cellular uptake efficiency.
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used for control. Adapted from [7] with the permission of John Wiley and Sons, 2016. 
(a) The ean fl orescence intensity of -3 cells tr t it l
fl y-3 in complex with self-assembled nanovectors 4, 5 and 6 (50 nM siRNA, N/P = 10).
Non-treated c lls and cells treated with labeled siRNA alone were us d as control. (b) siRNA release
from their complexes with micelles of dendrons 4 (red), 5 (black), and 6 (yellow) as assessed u ing EB
displacement assay performed in the prese ce of heparin. Adapted from [7] with the permission of
John Wiley and Sons, 2016.
ith this aspect ruled out, it was reasoned that the siRNA release of its nanovector could be the factor
underlying the best performance in gene silencing of the 4/siRNA complex. Thus, it was determined that it
was the dissociation of the nucleic acid fragments from their 4, 5, and 6 self-assembled nanovectors via the EB
displacement assay in the presence of heparin, a highly negatively charged polysaccharide that can compete
with siRNA in nanocarrier binding. As can be seen in Figure 5b, by increasing heparin concentration the
siRNA molecules were more efficiently displaced from their complex with 4 than from the two alternative
dendron micelles. This led us to the conclusion that the siRNA release process might be more effective from
the self-assembled dendron 4 than from the 5 and 6 co plexes, respectively.
Collectively, these results led to the conclusion that, in agreement with computer predictions,
the supermolecular assemblies formed by 5 a d 6 were actually too stable to disse ble in physiological
conditions. This enhanced stability negatively affects the siRNA release in the cellular environment,
thereby impairing the relevant ge e silencing effect. At the same time, the complexes of micelles originated
by dendron 4 and siRNA represent the best compromise in term of nucleic acid fragment binding and
release efficiency, and these properties ultimately translate into the most potent biological performance.
The final step of the in vitro characterization concerned the investigation of the cellular toxicity of
our single-tail self-asse bled dendrons. As shown in Figure 6 for the PC-3 cell line as an example,
none of the self- and non-self-assembling dendrons were endowed with cytotoxic properties. Analogous
results were obtained with the alternative prostate cancer cell line, C4-2.
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Figure 6. Metabolite toxicity (a) and membrane da aging activity (b) of self- and non-self-assembling
dendrons 1–8 and their complexes with a scrambled (i.e., non-silencing) siRNA sequence (50 nM siRNA,
N/P = 10) in PC-3 cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
assay and the lactate dehydrogenase (LDH) assay, respectively. Untreated cells were used for control.
Adapted from [7] with the permission of John Wiley and Sons, 2016.
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In essence, all in silico and in vitro results concurred to indicate 4 as the amphiphilic dendron
endowed with the best features for efficient self-assembly, and easy and stable formation of complexes
with the siRNA molecules for delivery. Once inside the cell, there is effective disassembly during
endosomal release for subsequent potent gene silencing.
2.4. In Vivo siRNA Delivery Performance of Single-Tail Self-Assembling Dendron 4
The in vitro best performing nanomicelles generated by the dendron 4 were finally challenged for
in vivo gene silencing in a prostate cancer xenografted nude mouse model. The results obtained are
gathered in Figure 7.
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tumors (30–50 mm3) with Hsp27 siRNA delivered by the self-assembling dendron 4, buffer solution 
(control), the dendron 4 alone, and a scrambled siRNA/4 complex (negative controls). Treatments (3 
mg/kg siRNA, N/P = 5) were administered for a period of 4 weeks via intraperitoneal injections (twice 
per week). (b) In vivo inhibition of tumor growth quantified by tumor size and (c) antiproliferation 
activity in tumors assessed by immunohistochemistry in mice treated as described for panel (a). Panel 
(c), from left to right: control, 4 alone, 4/siRNA, 4/scrambled siRNA. Adapted from [7] with the 
permission of John Wiley and Sons, 2016. 
Images in Figure 7 support the effective and specific in vivo gene silencing induced upon 
administration of the Hsp27-directed siRNA delivered by the self-assembled nanovector 4. In 
particular, an impressive reduction of ~80% in Hsp27 expression and of ~65% in tumor size after 4 
weeks of treatment were achieved (Figure 7a,b). 
These data, coupled with no discernable signs of in vivo toxicity (Figure 8) and the absence of 
mice weight loss, support the potential utilization of the amphiphilic compound 4 as a siRNA vector 
for future therapeutic implementations. 
Figure 7. (a) In vivo gene silencing achieved by treating nude mice bearing prostate cancer (PC-3)
tumors (30–50 mm3) with Hsp27 siRNA delivered by the self-assembling dendron 4, buffer solution
(control), the dendron 4 alone, and a scrambled siRNA/4 complex (negative controls). Treatments
(3 mg/kg siRNA, N/P = 5) were administered for a period of 4 weeks via intraperitoneal injections (twice
per week). (b) In vivo inhibition of tumor growth quantified by tumor size and (c) antiproliferation
activity in tu ors assessed by immu ohistochemi t y in mice treate as described for panel (a).
Panel (c), from left t right: co trol, 4 alone, 4/siRNA, 4/scrambled siRNA. Adapted from [7] with the
permission of John Wiley and Sons, 2016.
Images in Figure 7 support the effective and specific in vivo gene silencing induced upon
administration of the Hsp27-directed siRNA delivered by the self-assembled nanovector 4. In particular,
an impressive reduction of ~80% in Hsp27 expression and of ~65% in tumor size after 4 weeks of
treatment were achieved (Figure 7a,b).
These data, coupled with no discernable signs of in vivo toxicity (Figure 8) and the absence of
mice weight loss, support the potential utilization of the amphiphilic compound 4 as a siRNA vector
for future therapeutic implementations.
Pharmaceutics 2019, 11, 324 10 of 26har ace tics 2019, 11, x FOR PEER REVIEW 10 of 26 
 
   
(a) (b) (c) 
   
(d) (e) (f) 
 
(g) 
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aminotransferase AST (solid bars), alanine transferase ALT (patterned bars), gamma-glutamine 
transferase γ-GLT (empty bars), (e) kidney functions (creatinine CRE (mmol/L, solid bars), blood urea 
nitrogen BUN (μmol/L, patterned bars), and (f) cholesterol level in the blood measured in the treated 
mice after sacrifice. (g) Pathology of major organs from treated mice (HES staining). Columns (from 
left to right): Control, 4, 4/siRNA, and 4/scrambled siRNA. Rows (from top to bottom): Heart, kidney, 
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3. siRNA Delivery by Double-Tail Self-Assembling Amphiphilic Dendrons
3.1. Design, Optimization and Chemico-Physical Charactrization of Double-Tail Self-Assembling
Amphiphilic Dendrons
With the haste of further improving the siRNA delivery and related gene silencing performance of
the lead self-assembling amphiphilic dendron 4, it was questioned whether increasing its hydrophobic
portion would render this molecule even more efficient and effective. According to the devised strategy,
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it was ultimately decided to decorate 4 with a second C18-long alkyl chain. In order to do so, a series
of computer-based molecular design and optimization studies were carried out, finally leading to
the new double-tail amphiphilic dendron structure AD (where AD stands for Amphiphilic Dendron)
shown in Figure 9a [6]. In buffer solution per se, molecular simulations predicted AD to self-assemble
into large (~200 nm) vesicle-like structures (Figure 9b) called dendrimersomes [16]. After synthesis of
AD by click-chemistry, dynamic light scattering (DLS) and transmission electron microscopy (TEM)
indeed confirmed both the size and the shape of the supermolecular entities formed by AD upon
self-assembly (Figure 9c). Notably, the vesicle corona structure closely matched a bilayer, characterized
by a thickness of 7 nm—approximately equal to twice the molecular length of AD (~3.5 nm).
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Figure 9. (a) The structure of the double-tail mphi lic den ron simulated (b) and experimental TEM
images (c) of the vesicle-lik dendr mersomes formed by AD alone upon self-assembling in buffer solution.
In panel b, the hydrophilic units of AD are portrayed in light green, the hydrophobic units are de icted
in dark green, while light grey spheres are used to show some repr sentative water molecules. Simulated
(d) and experiment l TEM images (e) of th anosized spherical micelles formed by AD in the presence of
siRNA molecules in solution. In panel (d), colors as in panel (b), while the nucleic acid fragme ts are
portrayed as orange sticks. Adapted from [6] with permission of John Wiley and Sons, 2014.
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Quite surprisingly, however, when simulations of the self-assembly of AD were performed in the
presence of siRNA many highly ordered smaller spherical micelles of 6–8 nm diameter were obtained,
with the siRNA fragments nicely interspersed within them (Figure 9d). The explanation for this
vesicular to micellar structural transition likely resides in the greater positively charged surface area
exposed by the micelles with respect to the dendrimersomes, which provides more efficient electrostatic
interactions with the negatively charged siRNA. This, in turn, leads to the formation of more stable
and compact complexes between the self-assembled nanocarriers and the nucleic acids molecules.
The computer predictions were supported by TEM imaging (Figure 9e), confirming that AD is able to
dynamically self-assemble into responsive and adaptive supramolecular assemblies in the presence of
external stimuli, i.e., negatively-charged small polyanions.
3.2. In Vitro siRNA Delivery Performance of the Double-Tail Self-Assembling Dendron AD
The nanosized micelles formed by self-assembly of the double-tail amphiphilic dendron AD
were able to effectively protect siRNA from degradation (e.g., by RNAses) and to promote fast and
quantitative uptake by castrate-resistant prostate cancer PC-3 cells—almost 100% internalization of
the nanovector/siRNA complexes was reached within 30 min. As concerns the mechanism of cell
internalization of the AD/siRNA complexes, macropinocytosis was found to be the leading cellular entry
mechanism for this nanovector/siRNA system, in utter analogy with the G5 covalent PAMAM dendrimer
counterpart discussed in the companion paper (Figure 15a in [9]). Indeed, neither chlorpromazine
(an inhibitor of clathrin-mediated endocytosis) nor genistein (a caveolae-mediated uptake specific
blocker) were effective while cytochalasin D (a specific macropinocytosis inhibitor that, by binding
to actin filaments, interferes with actin polymerization and assembly) inhibited cellular uptake
in a dose-dependent manner, as presented in Figure 10b. Again in analogy with what observed for the
G5 TEA-core PAMAM covalent dendrimer (Figure 15b in [9]), confocal microscopy provided images
showing significant co-localization of the siRNA/AD complexes with the macropinocytosis biomarker
dextran. Whereas, negligible co-localization was observed in cells treated with the two alternative
biomarkers transferrin (clathrin-mediated endocytosis) and CTX-B (caveolae-mediated endocytosis).
Thus, these experiments further corroborate the concept that these self-assembling PAMAM-based
amphiphilic dendrons behave very similarly to their covalent high generation counterpart.
The gene silencing effect induced by Hsp-27 targeting siRNA delivered by AD nanomicelles
was next investigated both at the mRNA and protein levels using prostate (PC-3) and breast (MCF-7
and MDA-MB231) cancer cell lines. As seen in Figure 10, a remarkable attenuation of the Hsp27
expression was achieved in all cases. This effect was comparable, if not greater, than that achieved with
Lipofectamine, the reference standard reagent for siRNA/DNA transfection (e.g., AD was 6 times more
efficient than Lipofectamine in downregulating Hsp27 protein expression in PC-3 cells, Figure 10b).
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internalization of the AD/siRNA complexes, macropinocyto is was found to be the leading cellular 
entry mechanism for this nanovector/siRNA system, i  utter analogy with the G5 covalent PAMAM 
dendrimer counterpart discussed in the companion paper (Figure 15a in [9]). Indeed, neither 
chlorpromazine (an inhibitor of clathrin-mediated endocytosis) nor genistein (a caveolae-mediated 
uptake specific blocker) were effective while cytochalasin D (a specific macropinocytosis inhibitor 
that, by binding to actin filaments, interferes with actin polymerization and assembly) inhibited 
cellular uptake in a dose-dependent manner, as presented in Figure 10b. Again in analogy with what 
observed for the G5 TEA-core PAMAM covalent dendrimer (Figure 15b in [9]), confocal microscopy 
provided images showing significant co-localization of the siRNA/AD complexes with the 
macropinocytosis biomarker dextran. Whereas, negligible co-localization was observed in cells 
treated with the two alternative biomarkers transferrin (clathrin-mediated endocytosis) and CTX-B 
(cav olae-mediated endocytosis). Thus, th se experiments further corroborate the concept that these 
self-assembling PAMAM-based amphiphilic dendrons behave very similarly to their covalent high 
generation counterpart. 
The gene silencing effect induced by Hsp-27 targeting siRNA delivered by AD nanomicelles was 
next investigated both at the mRNA and protein levels using prostate (PC-3) and breast (MCF-7 and 
MDA-MB231) cancer cell lines. As seen in Figure 10, a remarkable attenuation of the Hsp27 
expression was achieved in all cases. This effect was comparable, if not greater, than that achieved 
with Lipofectamine, the reference standard reagent for siRNA/DNA transfection (e.g., AD was 6 
times more efficient than Lipofectamine in downregulating Hsp27 protein expression in PC-3 cells, 
Figure 10b). 
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Figure 10. Downregulation of Hsp27 at the (a) and protein (b) level in prostate cancer PC-3
cells treated with siRNA (50 nM) delivered by the self-assembled double-tail dendron AD (N/P = 5).
Inhibition of Hsp27 expression by siRNA/AD complexes (50 nM siRNA, N/P = 5) in breast cancer
MCF-7 (c) and MDA-MB231 (d). Adapted from [6] with permission of John Wiley and Sons, 2014.
The knockdown of Hsp27 in these cancer cells by siRNA delivered by AD micelles was paralleled
by significant anti-proliferative effects (~75% of cancer cell growth inhibition), in agreement with
the evidence that Hsp27 silencing negatively affects PC-3 cell survival [9,17]. Similarly to what was
observed for the high generation covalent PAMAM dendrimers [9], the mechanism leading to cell death
relied on caspase-dependent induced apoptosis, that i , th programmed cell death was pr moted by
apopto caspases, a family of endoproteases that provide critical links in cell regulato y networks
controlling cell death. Accordingly, a 3-fold increase in caspase-3/7 activation was observed on average,
confirming that siRNA delivered by the nanovectors based on self-assembled AD is very effective
in silencing Hsp27 and thereby inducing caspase-dependent anticancer activity in vitro. A remarkable
additional feature of this biological outcome is that the silencing effect was completely maintained
for one week, and was also effective when transfection was performed in the presence of serum,
a prototypical Achilles’ heel of cationic nanovectors in siRNA delivery. In fact, the negatively charged
serum proteins can not only compete with siRNA binding to the nanocarrier, but also may, by virtue
of strong electrostatic forces, lead to the the disintegration of the nanoassemblies with consequent
premature nucleic acid release and d gradation [9].
From another perspective, when confronted with its single-tail analogue 4, the efficiency of
in vitro silencing induced by the double-tailed AD dendron/siRNA complexes was practically identical
(e.g., 97% for AD and 96% for 4 in PC-3 cells, Figure 10b,c, respectively). Most importantly, however,
remarkably good results were obtained with AD when challenged against cancer stem cells (notoriously
the cancer cell population most refractory to treatments), and also stem and primary cells that constitute
the target of deadly viruses such as HIV-1. As shown in Figure 11, AD was indeed able to elicit
significant RNAi interference (RNAi) in glioblastoma stem cells (PBT003), and in HIV-1 infected human
primary peripheral blood mono uclear cells (PBMC-CD4+), and hematopoietic stem cells (HSC-CD34+).
Spec ficall , upon t eatment f the hardly tractable PBT003 cells with AD carrying the siRNA was
directed against the signal transducer and activator of transcription 3 (STAT3), which is a key player
protein in glioma-initiating cells, thought to be responsible for glioblastoma induction, progression and
recurrence. A 35% reduction in the corresponding mRNA level was observed, while only 24% mRNA
reduction was achieved upon transfection with Lipofectamine (Figure 11a). The data relative to the two
HIV-infected cell lines (PBMC-CD4+ and HSC-CD34+) transfected with the siRNA targeting the HIV-1
Tat/Rev gene are more striking. The Tat and Rev HIV-1 proteins are essential positive regulators of
gene expression through interaction with RNA target elements present within the 5′ translated leader
sequence and envelope g ne, res ectiv ly. Importantly, the genes encode the Rev and Tat overlap,
with each being produced from a different reading frame. As seen from Figure 11b,c, in both cases
a remarkable 50% reduction in the Tat/Rev mRNA expression was observed, while the prototypical
delivery vector Lipofectamine (aka RNAiMAX) failed to induce any gene silencing in these cells
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infected by the acquired immunodeficiency syndrome (AIDS) virus. Fundamentally, this translated
into a 50% reduction of the viral infection (Figure 11d,e) and, to the best of the authors’ knowledge,
constitutes the first report on the successful and safe delivery of siRNA into primary and stem cells.
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by NL4-3 virus at a multiplicity of infection (MOI) = 0.001 and by JR-FL virus (MOI = 0.005), 
respectively, for 5 days before transfection. (f) Proton-sponge effect in PC-3 cells transfected with 
siRNA/AD in the absence (solid bars) and presence (patterned bars) of the proton pump inhibitor 
Bafilomycin A1. Untreated cells were used as the control. Adapted from [6] with permission of John 
Wiley and Sons, 2014. 
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and, therefore, potent siRNA delivery within the cell cytoplasm. According to the debated proton 
sponge concept, when cationic nanoparticles such as those formed by AD and its siRNA cargo enter 
acidic endosomal (and lysosomal) vesicles, unsaturated amino groups sequester protons supplied by 
the proton pump v-ATPase. These sequestered protons cause the pump to continue functioning, 
leading to the retention of chloride ions and water molecules. Eventually, osmotic swelling causes 
the rupture of the vesicle, allowing the cationic nanoparticles to enter the cytoplasm. As the AD 
amphiphiles feature tertiary amines in the interior of their PAMAM heads which become protonated 
at the endosomal acidic pH (5.5), the authors verified whether the proton sponge effect was 
effectively at play also during their mediated siRNA delivery. Indeed, as illustrated in Figure 11f, 
Hsp27 silencing in PC-3 cells was significantly reduced in the presence of Bafilomycin A1 (a proton 
pump inhibitor that prevents endosome acidification). This implies that the AD-mediated siRNA 
Figure 11. (a) STAT3 knockdown in glioblast ma stem cells (PBT003) treated with siRNA/AD complexes
(50 nM siRNA, N/P = 5). The knockdown of Tat/Rev in primary human peripheral blood mononuclear
cells (PBMC-CD4+) (b) and hematopoietic CD34+ stem cells (HSC-CD4+) (c) treated as in (a). Effective
inhibition of HIV replication in PBMC-CD4+ (d) and HSC-CD4+ (e) after treatment with the anti-Tat/Rev
siRNA delivered by AD (50 nM siRNA, N/P = 5). Viral loading was assessed using HIV-1 p24 antigen
ELISA 3 days post-treatment. PBMC-CD4+ cells and HSC-CD34+ cells were infected by NL4-3 virus
at a multiplicity of infection (MOI) = 0.001 and by JR-FL virus (MOI = 0.005), respectively, for 5 days
before transfection. (f) Proton-sponge effect in PC-3 cells transfected with siRNA/AD in the absence
(solid bars) and prese c (patt rned bars) of the proton pump inhibitor Bafilomycin A1. Untreated
cells were used as the control. Adapted from [6] with permission of John Wiley and Sons, 2014.
As for the hig en ration covalent PA drimer analogues pres nted in the companion
paper [9], it was re soned that also in the case of the AD micelles, the so-calle t ge effect [18]
could be invoked to explain nucleic acid release from the self-assembled double-tail nanovectors and,
therefore, potent siRNA delivery within the cell cytoplasm. According to the debated proton sponge
concept, when cationic nanoparticles such as those formed by AD and its siRNA cargo enter acidic
endosomal (and lysosomal) vesicles, unsaturated amino groups sequester protons supplied by the
proton pump v-ATPase. These sequestered protons cause the pump to continue functioning, leading to
the retention of chloride ions and water molecules. Eventually, osmotic swelling causes the rupture of
the vesicle, allowing the cationic nanoparticles to enter the cytoplasm. As t e AD a phiphiles feature
tertiary amines in the interior of their PAMAM heads whic becom t nated at the endo omal
acidic pH (5.5), the authors ve ified whether the proton sponge effect was effectively at play also during
their mediated siRNA delivery. Indeed, as illustrated in Figure 11f, Hsp27 silencing in PC-3 cells
was significantly reduced in the presence of Bafilomycin A1 (a proton pump inhibitor that prevents
endosome acidification). This implies that the AD-mediated siRNA delivery was indeed dependent on
the endosomal acidification process and that the proton sponge effect played a role in the endosomal
escape and cytoplasmic release of the nucleic acid.
Finally, the same protocol adopted for investigating the cellular toxicity of the single-tail
self-assembled dendrons described in Section 2.3 was applied to AD. As expected, no discernible
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toxicity was observed in all cell lines (PC-3, PBMC-CD4+, HSC-CD34+, and PBT003 transfected with
50 nM siRNA and AD at N/P = 5 and 10) using both the MTT and LDH assays, supporting further
in vivo gene silencing experiments with this nanocarrier.
3.3. In Vivo siRNA Delivery Performance of the Double-Tail Self-Assembling Dendron AD
The final steps to assess the therapeutic potential of siRNA delivery based on the double-tail
self-assembled amphiphilic dendron AD were constituted by in vivo experiments using prostate cancer
(PC-3) xenograft mouse models and Hsp27 as the target gene for knockdown. Figure 12a,b reveal that,
following a 5-week animal treatment by intraperitoneal injections (2/week) of siRNA/AD complexes
(3 mg/kg Hsp27 siRNA, AD at N/P = 5), there was a remarkable downregulation of Hsp27 at both
mRNA (62%) and protein (73%) levels. This was paralleled by an effective inhibition of tumor growth,
as shown in Figure 12c. Further, as for the case of the single-tail amphiphilic analogue 4, no major
organ injury or histopathological changes were evidenced in the animal subjected to AD/siRNA
treatments (Figures 12d and A2).
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siRNA and AD at N/P = 5, injection twice a week for 5 weeks). Hsp27 mRNA and protein levels were 
quantified by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western 
blotting, respectively. Non-treated mice were used for the control. AD alone, siRNA alone and a 
scrambled (non-silencing) siRNA sequence delivered by AD were used as negative controls. (c) 
Tumor volume during treatment of PC-3 mice xenografts with siRNA/AD complexes (red symbols), 
compared with non-treated animals (green), and animals treated by AD alone (light blue), siRNA 
alone (dark blue), and a scrambled (non-silencing) siRNA sequence delivered by AD (gray symbol) 
used as negative controls. (d) Hepatic enzyme levels (alanine transferase ALT (light green bars), 
Figure 12. In vivo effective gene silencing of Hsp27 at the mRNA (a) and protein (b) levels observed
in prostate cancer (PC-3) xenograft mice after treatment with Hsp27 siRNA delivered by AD (3 mg/kg
siRNA and AD at N/P = 5, injection twice a week for 5 weeks). Hsp27 mRNA and protein levels
were quantified by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and
western blotting, respectively. Non-treated mice were used for the control. AD alone, siRNA alone
and a scra bled (non-s lencing) siRNA sequ nce delivered by AD were us d as negative controls.
(c) Tumor volume during treatme t of PC-3 mice xenografts with siRNA/AD complexes (red symbols),
compared with non-treated animals (green), and animals treated by AD alone (light blue), siRNA
alone (dark blue), and a scrambled (non-silencing) siRNA sequence delivered by AD (gray symbol)
used as negative controls. (d) Hepatic enzyme levels (alanine transferase ALT (light green bars),
gamma-glutamine transferase γ-GLT (teal bars), (kidney functions (creatinine CRE (mmol/L, sky blue
bars), blood urea nitrogen BUN (µmol/L, dark blue bars), and cholesterol level in the blood (gray bars,
values on the right axis) measured in male C57BL/6 mice treated with intravenous administration of
siRNA/AD (3 mg/kg siRNA and AD at N/P = 5). Untreated mice were used for control. Adapted
from [6] with permission of John Wiley and Sons, 2014.
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In summary, the nanosized micelles generated upon self-assembly of the double-tail amphiphilic
PAMAM-based dendron AD were not able to deliver siRNA to a different panel of cancer cell
lines with efficiency in vitro and in vivo comparable to those formed by its single-tail precursor 4.
However, they were also capable of eliciting gene silencing effects in the highly challenging and
treatment-refectory human primary cells and stem cells. Accordingly, these versatile and safe delivery
properties of AD, coupled with easy formulation, render AD a promising nanocarrier for highly
efficient, cell-type-independent RNAi therapeutics.
4. siRNA Delivery by the Double-Tail, Dual Targeting Self-Assembling Amphiphilic
Dendron AD/E16G6RGDK
4.1. Design, Optimization and Chemico-Physical Charactrization of the Double-Tail, Dual Targeting
Self-Assembling Amphiphilic Dendron AD/E16G6RGDK
In the general design strategy of nanocarriers to achieve effective siRNA (and in general drug)
delivery, two well-known criteria must be satisfied: (i) The delivered therapeutic is be able to reach the
desired disease (e.g., tumor) site(s) after administration with minimal loss in their quantity and activity
during their journey in the blood stream; and (ii) they only affect diseased cells without exerting
harmful effects to healthy organs and tissues. These requirements may be enabled using two strategies:
Passive and active drug targeting of drugs. The former approach relies on the (still controversial)
intrinsic enhanced permeability and retention effect (EPR) [19,20], according to which molecules
with size in the nanometer range tend to accumulate in diseased (especially tumor) tissues much
more than they do in normal tissues, thereby leaving little space for specific molecular design and
optimization. Active targeting employs directed intermolecular interactions (e.g., ligand binding to
disease-overexpressed receptors or other molecular recognition processes) to confer more specificity
to the delivery system. In the end, besides enhanced therapeutic action, active targeting can result
in reduced non-specific interactions and localization of the drug in peripheral tissues, thus minimizing
unwanted side-effects. One of the biggest challenges in active targeting consists in designing new
nanovectors (or modifying existing performing ones) with targeting moieties that do not interfere with
its cargo loading capacity and its final mission purposes. Obviously, these chemical entities must be
fully available to interact with their cellular counterparts and be endowed with strong affinity towards
their targets (e.g., surface receptors) in order to trigger endocytosis.
With the goal of empowering the high-performance double-tail self-assembling amphiphilic
dendron AD with active targeting ability for siRNA specific delivery to cancer cells, the authors
considered the RGDK peptide as the starting point for molecular design and optimization. The RGDK
peptide is an ideal moiety for cancer targeted nanomedicine in that it features a dual targeting capacity
within a single, small molecular scaffold. On the one side, the RGD sequence is known to be able
to target tumor endothelium via interaction with ανβ3-integrin (a receptor overexpressed in tumor
vasculature [21]); while on the other side, the RGDK sequence has been shown to bind the neutropilin-1
(Nrp-1, a transmembrane hub receptor with multiple ligands that is abundant on the surface of cancer
cells [22]), and in so doing, promoted cell uptake and penetration.
Several sequence rounds of computer optimization led to the final design of the E16G6RGDK
peptide shown in Figure 13a [8]. This new chemical entity features three distinct segments serving
different functions, as follows: (1) A highly negatively charged tail composed of 16 glutamic acid
residues (E16), for anchoring the peptide to the positively charged surface of the self-assembled AD
micelles via strong, favorable electrostatic interactions; (2) the positively charged RGDK warhead
for fostering cancer cell targeting and homing by virtue of the dual interaction with ανβ3-integrin
and Nrp-1 receptors; and (3) a neutral spacer of optimal length composed of 6 glycine residues (G6)
separating the oppositely charged segments, (1) and (2).
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corresponding ITC raw data. Adapted from [8] with permission of the American Chemical Society, 
2018. 
With the optimized new peptide structure at hand, and the previous knowledge about the self-
assembling process of AD and its related performance as siRNA nanocarrier (Section 3), the authors 
initially verified the interaction of the E16G6RGDK molecules with pre-formed siRNA/AD complexes 
in solution by means of different experimental techniques. Both DLS and TEM confirmed the 
formation of nanosized (30–45 nm in diameter) spherical micelles (shown in Figure 13b), 
characterized by a ζ-potential value of +15 mV, approximately equal to half of the value measured 
for the siRNA/AD assemblies (+32 mV). This substantial decrease in positive surface charges further 
supported the interaction of the negatively charged (−15) peptide with the siRNA/AD complexes. 
However, the ultimate confirmation of the effective binding of the E16G6RGDK targeting 
peptides to the siRNA/AD nanomicelles was obtained by isothermal titration calorimetry (ITC). ITC 
is a straightforward and noninvasive titration-based method for binding interaction analysis 
performed in solution at constant temperature [23]. The analysis of ITC curves directly yields the 
binding enthalpy (ΔHbind) and, upon data fitting with a suitable thermodynamic model, the binding 
constant Kb can be obtained. Once Kb is known, the free energy of binding ΔGbind is calculated using 
the relationship ΔGbind = −RT lnKbind, where R is the universal gas constant and T is the absolute 
temperature. Finally, the variation in entropy upon binding is derived from the fundamental Gibbs 
equation ΔGbind = ΔHbind − TΔSbind. The binding thermodynamics between the targeting peptides and 
the siRNA/AD micelles was found to be characterized by a favorable (i.e., negative) enthalpic 
variation (ΔHbind = −5.0 ± 0.2 kcal/mol), as evidenced by the exothermic peaks in the corresponding 
thermogram (Figure 13c). Also, a small, favorable (i.e., positive) entropic change (TΔS = 1.9 kcal/mol) 
was estimated, leading to an overall favorable (i.e., negative) ΔGbind value of −6.8 kcal/mol. The 
substantial enthalpic nature of the binding between the RGKD peptide and the siRNA/AD micelles 
is the result of electrostatic forces as the main supramolecular interaction drivers. However, the 
favorable entropic contribution was ascribed to the stabilizing peptide/micelle hydrophobic 
interactions and the concomitant release of ions and water molecules into the bulk solvent [24–26]. 
The structure of the siRNA/AD/E16G6RGDK was next investigated at the molecular level via 
computer simulations. Extensive (1 μs) atomistic molecular dynamics (MD) simulations revealed the 
formation of stable, Janus-like nanoparticles featuring a siRNA molecule bound on one face of each 
AD micelle and 4 peptides adsorbed on the opposite face (Figure 14a). Further, MD simulations 
showed that the negatively charged peptide tails (E16G6) were adsorbed onto the positively charged 
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With the optimized new peptide structure at hand, and the previous knowledge about the
self-assembling rocess of AD and ts related p rformance as siRNA nanocarrier (Section 3), the authors
initially verified the interaction of the E16G6RGDK molecules with pre-fo med siRNA/AD complexes
i solution by means of differe t experimental techniques. Both DLS and TEM confirmed the formation
of nanosized (30–45 nm in diameter) spherical mi elles (shown in Figure 13b), characterized by
a ζ-potential value of +15 mV, approximately equal to half of the valu measured for the siRNA/AD
assemblies (+32 mV). This substantial decrease in positive surface charges further supported the
interaction of the negatively charged (−15) peptide with the siRNA/AD complexes.
However, the ultimate confirmation of the effective binding of the E16G6RGDK targeting
peptides to the siRNA/AD nanomicelles was obtained by isothermal titration calorimetry (ITC).
ITC is a straightforward and noninvasive titration-based method for binding interaction analysis
performed in solution at constant temperature [23]. The analysis of ITC curves directly yields the
binding enthalpy (∆Hbind) and, upon data fitting with a suitable thermodynamic model, the binding
constant Kb can be obtained. Once Kb is known, the free energy of binding ∆Gbind is calculated using
the relationship ∆Gbind = −RT lnKbind, where R is the universal gas constant and T is the absolute
temperature. Finally, the variation in entropy upon binding is derived from the fundamental Gibbs
equation ∆Gbind = ∆Hbind − T∆Sbind. The binding thermodynamics between the targeting peptides and
the siRNA/AD micelles was found to be characterized by a favorable (i.e., negative) enthalpic variation
(∆Hbind = −5.0 ± 0.2 kcal/mol), as evidenced by the exothermic peaks in the corresponding thermogram
(Figure 13c). Also, a small, favorable (i.e., positive) entropic change (T∆S = 1.9 kcal/mol) was estimated,
leading to an overall favorable (i.e., negative) ∆Gbind value of −6.8 kcal/mol. The substantial enthalpic
nature of the binding between the RGKD peptide and the siRNA/AD micelles is the result of electrostatic
forces as the main supramolecular interaction drivers. However, the favorable entropic contribution
was ascribed to the stabilizing peptide/micelle hydrophobic interactions and the concomitant release
of ions and water molecules into the bulk solvent [24–26].
The structure of the siRNA/AD/E16G6RGDK was next investigated at the molecular level
via computer simulations. Extensive (1 µs) atomistic molecular dynamics (MD) simulations revealed
the formation of stable, Janus-like nanoparticles featuring a siRNA molecule bound on one face of
each AD micelle and 4 peptides adsorbed on the opposite face (Figure 14a). Further, MD simulations
showed that the negatively charged peptide tails (E16G6) were adsorbed onto the positively charged
surface micelle while, most importantly, the 4 RGDK warhead was free from sterical hindrance and
protruded deeply into the solvent (Figure 14b).
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These pictorial views were quantified first by calculating the radial distribution function (RDF)
from the AD micelle center of mass for the positively charged AD terminal groups and the 4 targeting
peptide RGDK warheads, as shown in Figure 14c. As seen from this Figure, all 4 RGDK moieties
are positioned far away from the nanomicelle periphery. Accordingly, they are potentially available
for interaction with their cellular target receptors. Next, the free energy of binding ∆Gbind of each
single E16G6RGDK peptide with the siRNA/AD nanomicelle was estimated by processing the MD
data according to the MM/PBSA methodology [9–15]. Figure 14d shows not only that all peptides
are characterized by favorable ∆Gbind values (from −7.0 to −6.2 kcal/mol), but also that the major
contribution to binding is afforded by the strong electrostatic interaction between the negatively
charged peptide tails (E16G6) and the positively charged micellar surface, as expected by the original
molecular design.
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4.2. In Vitro Targeted siRNA Delivery Performance of Double-Tail, Dual Targeting Self-Assembling
Amphiphilic Dendron AD/E16G6RGDK
The authors verified that the presence of the E16G6RGDK peptides on the surface of the siRNA/AD
micelles was indeed effective in specifically targeting cancer cells via dual binding with the designated
target receptors ανβ3integrin and Nrp-1. The cellular uptake of the siRNA/AD/E16G6RGDK complexes
was investigated again with PC-3 cells, in which both receptors were highly expressed [27,28]. As seen
in Figure 15a, the amount of siRNA/AD/E16G6RGDK complexes internalized by PC-3 cells was three
times higher than that measured for the siRNA/AD micelle. Further, the cellular uptake of the
nanocarrier modified with the targeting moieties was inhibited in the presence of a cyclic RGD peptide.
This clearly indicates that this last molecule competed with the peptide-coated nanovector for integrin
binding via the RDG motif.
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Next, PC-3 cells pretreated with a monoclonal antibody (mAb) directed against Nrp-1 were
used to assay the internalization of the siRNA/AD/E16G6RGDK nanoassemblies in comparison with
untreated cells. As can be easily seen in the corresponding confocal microscopy images (Figure 15b),
in the presence of the Nrp-1 mAb (bottom panel), the uptake of the siRNA-loaded peptide-modified
AD micelles was drastically reduced when the mAb was absent (upper panel). This indicates that
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the targeting peptide-decorated siRNA delivery system was effectively cell internalized also via its
interaction of its RGDK warhead with the Nrp-1 receptor.
Following verification of the successful attribution of the desired targeting properties to our
double-tail self-assembling AD nanovector, the authors checked whether its excellent endosomal escape
features, required for efficient siRNA delivery and release, was preserved. By confocal microscopy,
it was observed that 2 h after transfection, almost all of the siRNA molecules were localized in the cell
cytoplasm (Figure A3). This confirms that the peptide-decorated AD nanovectors were also able to
effectively circumvent endosomal trapping and release their nucleic acid cargo for subsequent RNAi.
The authors further assessed whether the endowment of the double-tail self-assembling dendron
AD with targeting properties eventually conferred by the RGDK-based peptides rendered this
nanovector more effective in siRNA delivery to cancer cells with respect to the undecorated AD micelles.
Their RNAi performance in silencing Hsp27 in PC-3 cancer cells was compared. The relevant results
showed that a remarkable Hsp27 knockdown was achieved both at the mRNA (56%, Figure 16a) and
the protein (90%) levels with a very low (20 nM) siRNA concentration (for comparison, a 50 nM siRNA
concentration was required to produce similar results either with the covalent G5 PAMAM dendrimer [9]
or with the AD micelles without targeting peptide decoration (Figure 10)). Moreover, the same
experiments performed in the presence of either the c-RGD peptide or the Nrp-1 directed mAb resulted
in a decreased gene silencing effect (as shown by the last two columns in Figure 16a). This confirms
that the siRNA/AD/E16G6RGDK nanoparticles indeed interact with the two target receptors.
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Follo ing si delivery to P -3 cells ith the peptide-decorated nano icelles, a drastic
anticancer activity was observed again using only a 20 nM siRNA concentration (Figure 16b).
This corresponds to an effect of 30% higher than that achieved with the pristine AD nanovectors.
onco itantly, the /E 6RGDK nanoassemblies exhibited a safe toxicity profile, si ilar to that
presented by the AD micelles (Figure A4), and in addition to its notable improvement in hemolytic effects
(Figure A4c). All these data led the authors to perform the final testing of the siRNA/AD/E16G6RGDK
nanoparticles in vivo.
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4.3. In Vivo Targeted siRNA Delivery Performance of Double-Tail, Dual Targeting Self-Assembling
Amphiphilic Dendron AD/E16G6RGDK
The in vivo gene silencing and anticancer effects of the peptide-decorated AD nanomicelles
was investigated again using PC-3 xenograft nude mice. The first analysis was conducted to
verify their enhanced tumor targeting ability with respect to the undecorated AD nanovectors
using a fluorescent-labeled Hsp27 siRNA. Accordingly, ex vivo imaging of isolated tumors and the
quantification of the relevant mean fluorescence intensity were performed (Figure 17a,b), from which
the substantially higher tumor accumulation of the targeted nanoparticles was substantiated.
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After 4 weeks of mice treatment with a very low siRNA concentration (0.25 mg/kg)—12-fold less
than the conventional concentration used for siRNA delivery in mice—both the tumor volume and the
corresponding levels of Hsp27 protein were drastically reduced when siRNA was administered via the
peptide-decorate AD nanovectors, as shown in Figure 17c,d. In particular, at day 31 after treatment
with the siRNA/AD/E16G6RGDK nanoparticles, tumor growth was reduced by 73% with respect to
the control and by 50% relative to siRNA/AD treatment (Figure 17c). Consistently, Hsp27 expression
in tumors was reduced by 65% and 41% upon siRNA treatment with the targeted nanovectors with
respect to the control and AD-delivered siRNA, respectively (Figure 17d).
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These highly promising results, coupled with the excellent in vivo toxicity profile exhibited by the
AD/E16G6RGDK nanocarriers confirmed the high potential for these targeting nanosystems as safe
and efficient siRNA delivery, gene silencing and consequent anticancer nanotherapeutics.
5. Conclusions
As defined by Nature.com [29], “self-assembly is the process by which an organized structure
spontaneously forms from individual components, as a result of specific, local interactions among
the components. When the constitutive components are molecules, the process is termed molecular
self-assembly”. A key feature of molecular self-assembly is the multivalent, cooperative and synergistic
nature of the intermolecular interactions leading to the organization of individual molecular entities into
well-defined nanosized structures. This approach presents at least two major conceptual advantages.
The first relies on the evidence that the driving forces governing self-assembly lead to the formation of
the nano-objects virtually with no flaws, as interactions between the nanomicelle building blocks are
mediated by specific molecular recognition ultimately resulting in complex and ordered nanoscale
structures. The second, by no means of less important benefit to self-assembly is that very small
amounts of material are required to accomplish the process.
In the companion paper [9], the authors presented the design, synthesis and gene silencing activity
of modified PAMAM-based covalent nanovectors for siRNA delivery in cancer therapeutics. However,
high generation dendrimer synthesis is extremely laborious and time-consuming, since the final
product purification is difficult and hampered by the presence of highly similar side products. Thus,
notwithstanding the highly promising results achieved with these molecules, the difficulties inherent
in large-scale good manufacturing practice (GMP) production of high generation dendrimers led the
authors to explore the potential of self-assembly in the design of new efficient siRNA nanocarriers.
Thus, as presented in this second short review, the small PAMAM-based amphiphilic dendron
4, composed by a PAMAM head and a C18-long hydrocarbon tail, was initially developed. This was
safe and effective in delivering siRNA both in vitro and in vivo. The natural evolution of 4 was
its double-tail counterpart AD. The in vivo gene silencing effect obtained with siRNA delivered by
AD nanomicelles in cancer treatment was comparable to that obtained with its precursor dendron 4.
However, AD nanovectors were also capable of eliciting gene silencing effects in the highly challenging
and treatment-refectory human primary cells and stem cells.
The RNAi results of both the amphiphilic dendrons 4 and AD could be mainly attributed to
passive targeting via the EPR effect in addition to their excellent siRNA delivery and endosomal escape
capabilities. The authors focused on equipping AD with the dual E16G6RGDK targeting peptide,
with the final goal of endowing the resulting nanovectors with cancer cell-directing specificity and,
accordingly, higher anticancer activity. Compared to AD, the peptide-decorated AD nanomicelles
exhibited more than 10-fold greater in vivo RNAi at significantly lower siRNA doses with respect to both
covalent PAMAM dendrimers [9] and the non-targeted AD nanovectors. Our current activity in the field
is progressing along this line, with the computer-assisted design of new targeting moieties for decorating
self-assembling nanovectors in the development of gene silencing-based personalized medicine against
different highly challenging and deadly (e.g., glioblastoma and pancreatic) human cancers.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4923/11/7/324/s1,
Figure S1. Schematic representation of the coarse-grained DPD model of the AD dendron. The different bead
types are colored as follows: RC, dark magenta; R, plum; L, dark turquoise; G, chartreuse; C, light gray. Table S1.
Example of DPD interaction parameters used to simulate the self-assembling of the amphiphilic dendron AD per
se and in the presence of siRNA molecules.
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Figure A4. (a) Toxicity assessment using the MTT assay in prostate cancer PC-3 cells (solid bars) and 
in human embryonic kidney (HEK293) cells (patterned bars) of the AD micelles alone, AD in complex 
with a non-silencing siRNA (nssiRNA/AD) and the targeting peptide-decorated AD in complex with 
a non-silencing siRNA (nssiRNA/AD/E16G6RGDK). (b) Toxicity assessment using the LDH assay in 
prostate cancer PC-3 cells (solid bars) and in human embryonic kidney (HEK293) cells (patterned 
bars) of the AD micelles alone, AD in complex with a non-silencing siRNA (nssiRNA/AD) and the 
targeting peptide-decorated AD in complex with a non-silencing siRNA (nssiRNA/AD/E16G6RGDK). 
(c) Hemolysis effect measured via UV absorption at 540 nm for the AD micelles alone, AD in complex 
with a non-silencing siRNA (nssiRNA/AD) and the targeting peptide-decorated AD in complex with 
a non-silencing siRNA (nssiRNA/AD/E16G6RGDK) at different AD concentrations (corresponding to 
nssiRNA concentrations of 10, 20, 50, 100, and 200 nM, respectively). In all these experiments, the 
siRNA/AD/E16G6RGDK nanoassemblies were prepared using 50 nM siRNA, siRNA/AD N/P = 10, and 
AD/E16G6RGDK molar ratio = 5. Adapted from [8] with the permission of the American Chemical 
Society, 2018. 
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